Beclometasone/formoterol explained

Type:combo
Component1:Beclometasone dipropionate
Class1:Glucocorticoid
Component2:Formoterol fumarate
Class2:Long-acting β2 agonist
Tradename:Fostair
Routes Of Administration:Inhalation
Atc Prefix:R03
Atc Suffix:AL09
Legal Au:S4
Legal Uk:POM
Legal Uk Comment:[1] [2] [3]

Beclometasone/formoterol, sold under the brand name Fostair, is an inhalable fixed-dose combination drug for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It contains beclometasone dipropionate and formoterol fumarate dihydrate. It is inhaled.

It was approved for medical use in the United Kingdom in 2007, and in Australia in February 2020.[4] [5] It is on the World Health Organization's List of Essential Medicines.[6]

Further reading

Notes and References

  1. Web site: Fostair 100/6 micrograms per actuation pressurised inhalation solution - Summary of Product Characteristics (SmPC) . (emc) . 3 March 2020 . 18 July 2020.
  2. Web site: Fostair 200/6 micrograms per actuation pressurised inhalation solution - Summary of Product Characteristics (SmPC) . (emc) . 13 February 2019 . 18 July 2020.
  3. Web site: Fostair NEXThaler 200 micrograms/6 micrograms per actuation inhalation powder - Summary of Product Characteristics (SmPC) . (emc) . 16 April 2019 . 18 July 2020.
  4. Web site: Australian Product Information - Fostair 100/6 (Beclometasone dipropionate and formoterol (eformoterol) fumarate dihydrate) pressurised inhalation solution . Therapeutic Goods Administration (TGA) . April 2020 . 22 September 2020.
  5. Web site: AusPAR: Beclometasone dipropionate/formoterol (eformoterol) fumarate dihydrate . Therapeutic Goods Administration (TGA) . 3 August 2020 . 22 September 2020.
  6. Book: ((World Health Organization)) . World Health Organization model list of essential medicines: 22nd list (2021) . 2021 . 10665/345533 . World Health Organization . World Health Organization . Geneva . WHO/MHP/HPS/EML/2021.02 . free .